Cell transplantation is inherently appealing as a po-Previous attempts using conventional techniques such as the incorporation of DiI (1) or latex beads (15) and tential treatment for a wide range of diseases characterized by the selective loss of cellular populations (6,10, the use of antibodies to P-cadherin (11), vimentin, and Fas ligand (8) have all been used to identify grafted Ser-12, 17, 21) . Despite significant advances in transplantation biology over the past 20 years, the field continues toli cells, but each of these approaches suffers from practical concerns and lack of specificity. The need for a to face numerous problems highlighted by limited human tissue sources and the need for chronic immunosup-selective means to identify Sertoli cells lies in the basic requirement to refine and optimize their potential use for pression to prevent immune-mediated destruction of grafted tissue derived from both human and nonhuman sources. clinical transplantation. Additionally, differential identification of Sertoli cells is essential because they may One potential strategy to overcome these obstacles creates an immunoprivileged site capable of maintaining ultimately provide a platform technology from which numerous and fundamentally different applications will the long-term viability of grafted tissue by harnessing the natural immunoregulatory capacity of Sertoli cells.
arise ranging from transplants of Sertoli cells alone to co-grafts of Sertoli cells and other distinctive cell types. Sertoli cells are normal constituents of the testes where they create a trophic-rich nurturing and immunoprotec-In this issue of Cell Transplantation two separate groups (4,7) have independently identified markers for tive environment (believed to be derived, in part, from the extensive production of cytokines and growth fac-Sertoli cells based on the presence in these cells of Mullerian inhibiting substance (MIS; also referred to as anti-tors), capable of supporting nontesticular grafts (2, 19, 22) . Indeed, the supportive and immunoprivileged na-Mullerian hormone or Mullerian inhibiting hormone) and Sox9. MIS is a thoroughly characterized 140 k gly-ture of the intratesticular environment has been well documented for over 60 years (5). Since that time, sev-coprotein produced by Sertoli cells localized within the endoplasmic reticulum. MIS possesses a wide range of eral studies have confirmed that isolated Sertoli cells can provide trophic support for nontesticular transplantable biological activities and is expressed to varying degrees throughout life. Because MIS and TGFβ share consider-cells (3,6,8,15) and can protect allogeneic and even xenogeneic tissue transplants in models of Parkinson's able homology at the conserved C-terminal region, MIS is currently regarded as a member of the TGFβ family. disease (1,11,13-16,23) and diabetes (8, 9, (18) (19) (20) 22, 24) . the ability to identify the grafted cells with precision
